Verdict in the case of therapies versus eosinophils

The jury is still out

Bruce S. Bochner

Research output: Contribution to journalArticle

Abstract

Eosinophils are regarded by many as fundamental to the pathophysiology of allergic diseases, including asthma. An improved understanding of the mechanisms involved in these responses is therefore of great relevance to asthma pathogenesis and the development of new therapeutics. Most therapies that are effective in reducing allergic inflammation in animals and human subjects diminish tissue eosinophilia and levels of eosinophil-derived mediators. However, recent efforts with more selective eosinophil-suppressive therapies have failed to affect disease, bringing into question the role of eosinophils in asthma. This article will provide a brief overview of the role of eosinophils in allergic diseases, followed by a discussion of both eosinophil-specific and eosinophil-selective therapeutic targets, with a focus on cell-surface molecules. The known and theoretic benefits and risks of these strategies will also be covered.

Original languageEnglish (US)
Pages (from-to)3-10
Number of pages8
JournalThe Journal of Allergy and Clinical Immunology
Volume113
Issue number1
DOIs
StatePublished - Jan 2004

Fingerprint

Eosinophils
Asthma
Therapeutics
Eosinophilia
Inflammation

Keywords

  • Asthma
  • Eosinophil
  • Phenotype
  • Targets
  • Therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Verdict in the case of therapies versus eosinophils : The jury is still out. / Bochner, Bruce S.

In: The Journal of Allergy and Clinical Immunology, Vol. 113, No. 1, 01.2004, p. 3-10.

Research output: Contribution to journalArticle

@article{fef4f0e15fa84b7ba0373fa3887671d9,
title = "Verdict in the case of therapies versus eosinophils: The jury is still out",
abstract = "Eosinophils are regarded by many as fundamental to the pathophysiology of allergic diseases, including asthma. An improved understanding of the mechanisms involved in these responses is therefore of great relevance to asthma pathogenesis and the development of new therapeutics. Most therapies that are effective in reducing allergic inflammation in animals and human subjects diminish tissue eosinophilia and levels of eosinophil-derived mediators. However, recent efforts with more selective eosinophil-suppressive therapies have failed to affect disease, bringing into question the role of eosinophils in asthma. This article will provide a brief overview of the role of eosinophils in allergic diseases, followed by a discussion of both eosinophil-specific and eosinophil-selective therapeutic targets, with a focus on cell-surface molecules. The known and theoretic benefits and risks of these strategies will also be covered.",
keywords = "Asthma, Eosinophil, Phenotype, Targets, Therapy",
author = "Bochner, {Bruce S.}",
year = "2004",
month = "1",
doi = "10.1016/j.jaci.2003.09.046",
language = "English (US)",
volume = "113",
pages = "3--10",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Verdict in the case of therapies versus eosinophils

T2 - The jury is still out

AU - Bochner, Bruce S.

PY - 2004/1

Y1 - 2004/1

N2 - Eosinophils are regarded by many as fundamental to the pathophysiology of allergic diseases, including asthma. An improved understanding of the mechanisms involved in these responses is therefore of great relevance to asthma pathogenesis and the development of new therapeutics. Most therapies that are effective in reducing allergic inflammation in animals and human subjects diminish tissue eosinophilia and levels of eosinophil-derived mediators. However, recent efforts with more selective eosinophil-suppressive therapies have failed to affect disease, bringing into question the role of eosinophils in asthma. This article will provide a brief overview of the role of eosinophils in allergic diseases, followed by a discussion of both eosinophil-specific and eosinophil-selective therapeutic targets, with a focus on cell-surface molecules. The known and theoretic benefits and risks of these strategies will also be covered.

AB - Eosinophils are regarded by many as fundamental to the pathophysiology of allergic diseases, including asthma. An improved understanding of the mechanisms involved in these responses is therefore of great relevance to asthma pathogenesis and the development of new therapeutics. Most therapies that are effective in reducing allergic inflammation in animals and human subjects diminish tissue eosinophilia and levels of eosinophil-derived mediators. However, recent efforts with more selective eosinophil-suppressive therapies have failed to affect disease, bringing into question the role of eosinophils in asthma. This article will provide a brief overview of the role of eosinophils in allergic diseases, followed by a discussion of both eosinophil-specific and eosinophil-selective therapeutic targets, with a focus on cell-surface molecules. The known and theoretic benefits and risks of these strategies will also be covered.

KW - Asthma

KW - Eosinophil

KW - Phenotype

KW - Targets

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0346869043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346869043&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2003.09.046

DO - 10.1016/j.jaci.2003.09.046

M3 - Article

VL - 113

SP - 3

EP - 10

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1

ER -